High-dose continuous infusion ifosfamide in the treatment of bone marrow infiltration with severe thrombocytopenia in a patient with Ewing sarcoma: a case report
Fabio Murtas(University of Padua), Antonella Brunello(Istituto Oncologico Veneto), Marta Burei(Istituto Oncologico Veneto), Benedetta Chiusole(Istituto Oncologico Veneto), Silvia Finotto(Istituto Oncologico Veneto), Marta Sbaraglia(University of Padua), Marina Coppola(Istituto Oncologico Veneto), Maital Bolshinsky(Istituto Oncologico Veneto), Antonella Galiano(Istituto Oncologico Veneto), Ilaria Tortorelli(Istituto Oncologico Veneto), Elena Bellan(University of Padua), Angelo Paolo Dei Tos(University of Padua)
Cited by 0
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k